Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Cassel

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Combinatorial Chemistry|May 10, 2005
The solid-phase Nicholas reaction: scope and limitationsNatalie Gachkova, Johan Cassel, Stefanie Leue, et al.
Bioorganic & Medicinal Chemistry Letters|September 27, 2012
Discovery of 4-morpholino-pyrimidin-6-one and 4-morpholino-pyrimidin-2-one-containing Phosphoinositide 3-kinase (PI3K) p110β isoform inhibitors through structure-based fragment optimisationFabrizio Giordanetto, Andreas Wållberg, Johan Cassel, et al.
Bioorganic & Medicinal Chemistry Letters|September 27, 2012
Discovery of phosphoinositide 3-kinases (PI3K) p110β isoform inhibitor 4-[2-hydroxyethyl(1-naphthylmethyl)amino]-6-[(2S)-2-methylmorpholin-4-yl]-1H-pyrimidin-2-one, an effective antithrombotic agent without associated bleeding and insulin resistanceFabrizio Giordanetto, Andreas Wållberg, Saswati Ghosal, et al.
Journal of Medicinal Chemistry|April 2, 2019
Novel Chemical Series of 5-Lipoxygenase-Activating Protein Inhibitors for Treatment of Coronary Artery DiseaseMalin Lemurell, Johan Ulander, Hans Emtenäs, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2016
Isoindolinone compounds active as Kv1.5 blockers identified using a multicomponent reaction approachJohan Kajanus, Ingemar Jacobson, Annika Åstrand, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Combinatorial Chemistry|May 10, 2005
The solid-phase Nicholas reaction: scope and limitationsNatalie Gachkova, Johan Cassel, Stefanie Leue, et al.
Bioorganic & Medicinal Chemistry Letters|September 27, 2012
Discovery of 4-morpholino-pyrimidin-6-one and 4-morpholino-pyrimidin-2-one-containing Phosphoinositide 3-kinase (PI3K) p110β isoform inhibitors through structure-based fragment optimisationFabrizio Giordanetto, Andreas Wållberg, Johan Cassel, et al.
Bioorganic & Medicinal Chemistry Letters|September 27, 2012
Discovery of phosphoinositide 3-kinases (PI3K) p110β isoform inhibitor 4-[2-hydroxyethyl(1-naphthylmethyl)amino]-6-[(2S)-2-methylmorpholin-4-yl]-1H-pyrimidin-2-one, an effective antithrombotic agent without associated bleeding and insulin resistanceFabrizio Giordanetto, Andreas Wållberg, Saswati Ghosal, et al.
Journal of Medicinal Chemistry|April 2, 2019
Novel Chemical Series of 5-Lipoxygenase-Activating Protein Inhibitors for Treatment of Coronary Artery DiseaseMalin Lemurell, Johan Ulander, Hans Emtenäs, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2016
Isoindolinone compounds active as Kv1.5 blockers identified using a multicomponent reaction approachJohan Kajanus, Ingemar Jacobson, Annika Åstrand, et al.
Pageof 1